|
Argentina Biotech News. Service for global professionals. Constantly updated news and information about Argentina.
Latest Argentina Biotech News
- CzechInvest and Argentina cooperate on investments 18 Dec 2009 14:15 GMT
... > > CzechInvest and Argentina cooperate on investments | CzechInvest | Recent ... the areas of mechanical engineering, the automotive industry, biotechnology, software development and renewable sources of energy.” ...
- Thallion Announces Letter of Intent With LFB Biotechnologies to Develop and Commercialize Shigamabs(R) 18 Dec 2009 14:40 GMT
... Thallion Announces Letter of Intent With LFB Biotechnologies to Develop and Commercialize Shigamabs Thallion to ... had been approved previously by both the Argentinean and Chilean regulatory agencies, the companies intend ... Thallion Pharmaceuticals Inc. (TSX:TLN) is a biotechnology company developing pharmaceutical products in the areas of ...
- Thallion Announces Letter of Intent with LFB Biotechnologies to Develop and Commercialize Shigamabs 18 Dec 2009 16:36 GMT
... Thallion Announces Letter of Intent with LFB Biotechnologies to Develop and Commercialize Shigamabs - Thallion ... had been approved previously by both the Argentinean and Chilean regulatory agencies, the companies intend ... Pharmaceuticals Inc. (TSX: TLN) is a biotechnology company developing pharmaceutical products in the areas of ...
- Thallion Announces Letter of Intent With LFB Biotechnologies to Develop and Commercialize Shigamabs(R) (CCN) 18 Dec 2009 14:42 GMT
... which no approved therapy currently exists. LFB Biotechnologies is an ideal partner for this program ... had been approved previously by both the Argentinean and Chilean regulatory agencies, the companies intend ... around the world: (TSX:TLN) is a biotechnology company developing pharmaceutical products in the areas of ...
- Thallion Announces Letter of Intent With LFB Biotechnologies to Develop and Commercialize Shigamabs(R) (MRW) 18 Dec 2009 14:42 GMT
... which no approved therapy currently exists. LFB Biotechnologies is an ideal partner for this program ... had been approved previously by both the Argentinean and Chilean regulatory agencies, the companies intend ... the world: (TSX: TLN) is a biotechnology company developing pharmaceutical products in the areas of ...
- Thallion Announces Letter of Intent With LFB Biotechnologies to Develop and Commercialize Shigamabs(R) Thallion to receive C$2.3 million up-front, as part of up to C$150 million in development funding & milestones, plus royalties, 18 Dec 2009 15:14 GMT
... Thallion Announces Letter of Intent With LFB Biotechnologies to Develop and Commercialize Shigamabs(R) Thallion to ... American rights MONTREAL, QUEBEC, Dec 18, 2009 (Marketwire via COMTEX News Network) -- Thallion Pharmaceuticals ... had been approved previously by both the Argentinean and Chilean regulatory agencies, the companies intend ...
- Thallion Announces Letter of Intent With LFB Biotechnologies to Develop and Commercialize Shigamabs(R) Thallion to receive C$2.3 million up-front, as part of up to C$150 million in development funding 18 Dec 2009 15:20 GMT
... Thallion Announces Letter of Intent With LFB Biotechnologies to Develop and Commercialize Shigamabs(R) Thallion to ... American rights MONTREAL, QUEBEC, Dec 18, 2009 (MARKETWIRE via COMTEX News Network) -- Thallion Pharmaceuticals ... had been approved previously by both the Argentinean and Chilean regulatory agencies, the companies intend ...
- We Want You To Sign Up For Our Newsletter!! AFPW,BKYI,CTEI,ISCO, LIEG, MDOR 17 Dec 2009 07:39 GMT
... sources. The Company also has been conducting biotechnology research, development and potential commercialization of technologies ... Inc.) LATEST NEWS!! BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine WALL, ... on identifying and acquiring opportunities in Peru, Argentina and Chile and the United States. Li3 ...
- www.standoutstocks.com: Stocks That Stand Out For Dec. 18th, 2009 Are Dec 18, 2009 - avVaa World Health Care Products Inc. (Pink Sheets: AVVH), Dec 18, 2009 - Gold Resource Corporation (OTC Bulletin Board: GORO), Dec 17, 2009 - Ca 18 Dec 2009 17:04 GMT
... Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded ... located in southern Peru, one in southern Argentina and one open pit mine in northern ... Since then, as an international alliance of industry, academia, government agencies, multilateral organizations and civil ...
- Lilly (Eli) & Co Lilly Outlines Innovation Strategy 10 Dec 2009 15:40 GMT
... actions, we have increased our portfolio of biotechnology-based molecules, which now represents over one-third of ... has also launched Efient in Australia and Argentina, and anticipates launching the medicine in 24 ... largest clinical stage oncology pipelines in the industry, with 23 assets - more than one-third ...
- Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10 Dec 2009 11:50 GMT
... actions, we have increased our portfolio of biotechnology-based molecules, which now represents over one-third of ... has also launched Efient in Australia and Argentina, and anticipates launching the medicine in 24 ... largest clinical stage oncology pipelines in the industry, with 23 assets - more than one-third ...
- Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 10 Dec 2009 11:57 GMT
... actions, we have increased our portfolio of biotechnology-based molecules, which now represents over one-third of ... has also launched Efient in Australia and Argentina, and anticipates launching the medicine in 24 ... largest clinical stage oncology pipelines in the industry, with 23 assets - more than one-third ...
- Lilly Outlines Innovation Strategy 10 Dec 2009 15:12 GMT
... actions, we have increased our portfolio of biotechnology-based molecules, which now represents over one-third of ... has also launched Efient in Australia and Argentina, and anticipates launching the medicine in 24 ... largest clinical stage oncology pipelines in the industry, with 23 assets - more than one-third ...
- Lilly Outlines Innovation Strategy and Sets 2010 Financial Guidance 10 Dec 2009 13:33 GMT
... actions, we have increased our portfolio of biotechnology-based molecules, which now represents over one-third of ... has also launched Efient in Australia and Argentina, and anticipates launching the medicine in 24 ... largest clinical stage oncology pipelines in the industry, with 23 assets - more than one-third ...
- Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance (PRN) 10 Dec 2009 11:54 GMT
... actions, we have increased our portfolio of biotechnology-based molecules, which now represents over one-third of ... has also launched Efient in Australia and Argentina, and anticipates launching the medicine in 24 ... largest clinical stage oncology pipelines in the industry, with 23 assets - more than one-third ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
Country Info About Argentina
| |
|
14 December 2009
11 December 2009
09 December 2009
|
a digital news provider
nationalgeographic.com:
un.org:
reuters.com:
bbc.co.uk: